Phibro Animal Health (NASDAQ:PAHC) Stock Price Down 6.5%

Phibro Animal Health Co. (NASDAQ:PAHC)’s stock price traded down 6.5% during trading on Wednesday . The stock traded as low as $12.73 and last traded at $12.73. 55,607 shares changed hands during mid-day trading, a decline of 61% from the average session volume of 140,861 shares. The stock had previously closed at $13.61.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Tuesday, April 9th.

Phibro Animal Health Stock Performance

The firm has a market capitalization of $508.72 million, a PE ratio of 36.11, a price-to-earnings-growth ratio of 4.83 and a beta of 0.75. The company has a debt-to-equity ratio of 1.66, a current ratio of 3.12 and a quick ratio of 1.60. The stock has a 50-day moving average price of $12.80 and a 200-day moving average price of $11.76.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Wednesday, February 7th. The company reported $0.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.06. The business had revenue of $249.90 million for the quarter, compared to analyst estimates of $242.91 million. Phibro Animal Health had a return on equity of 16.67% and a net margin of 1.51%. On average, research analysts expect that Phibro Animal Health Co. will post 1.12 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Wednesday, March 6th were paid a $0.12 dividend. The ex-dividend date was Tuesday, March 5th. This represents a $0.48 dividend on an annualized basis and a yield of 3.82%. Phibro Animal Health’s payout ratio is currently 133.33%.

Hedge Funds Weigh In On Phibro Animal Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Barclays PLC raised its holdings in Phibro Animal Health by 59.8% during the third quarter. Barclays PLC now owns 35,638 shares of the company’s stock worth $456,000 after purchasing an additional 13,332 shares in the last quarter. Trexquant Investment LP raised its holdings in Phibro Animal Health by 143.6% during the third quarter. Trexquant Investment LP now owns 35,872 shares of the company’s stock worth $458,000 after purchasing an additional 21,147 shares in the last quarter. Brandes Investment Partners LP raised its holdings in Phibro Animal Health by 38.5% during the third quarter. Brandes Investment Partners LP now owns 1,873,300 shares of the company’s stock worth $23,922,000 after purchasing an additional 520,697 shares in the last quarter. China Universal Asset Management Co. Ltd. raised its holdings in Phibro Animal Health by 358.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 2,357 shares of the company’s stock worth $27,000 after purchasing an additional 1,843 shares in the last quarter. Finally, New York State Common Retirement Fund increased its holdings in shares of Phibro Animal Health by 20.9% in the third quarter. New York State Common Retirement Fund now owns 69,944 shares of the company’s stock valued at $893,000 after buying an additional 12,110 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.